Home › Pulmonary Hypertension › Pennsylvania
Pulmonary Hypertension clinical trials in Pennsylvania
13 studies for Pulmonary Hypertension are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- University of Pittsburgh Medical Center, Mechanicsburg
Recruiting
Ages 18 to 85 · All sexes · Updated Oct 1, 2026 · NCT07214376Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA013, Philadelphia
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07179380Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Thomas Jefferson University, Philadelphia
- Temple University of The Commonwealth System of Higher Education, Philadelphia
Recruiting
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06911632Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass
- University of Pennsylvania Hospital, Philadelphia
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT07132788DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- St. Luke's University Health Network, Bethlehem
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University - Sidney Kimmel Medical College, Philadelphia
- and 2 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT06388421Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
RecruitingPhase 2
Ages 8 to 60 · All sexes · Updated Aug 14, 2026 · NCT03630211A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Temple University, Philadelphia
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Aug 10, 2026 · NCT07175038Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Abington Memorial Hospital, Abington
- Penn State Milton S. Hershey Medical Center, Hershey
- University of Pennsylvania, Philadelphia
- and 1 more
Recruiting
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT06526195iTONE Trial (exercIse Training in pulmONary hypertEnsion) Exercise Program for Pediatric PH
- Children's Hospital of Philadelphia, Philadelphia
Recruiting
Ages 8 to 18 · All sexes · Updated Apr 22, 2026 · NCT05442671Feasibility of Semaglutide in Advanced Lung Disease
- University of Pennsylvania Perelman School of Medicine, Philadelphia
RecruitingPhase 1/2
Ages 18 to 80 · All sexes · Updated Apr 21, 2026 · NCT05746039PET Image in PAH Patients
- Montefiore Hospital Clinical and Translational Research Center, Pittsburgh
RecruitingEarly phase 1Healthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Jan 21, 2026 · NCT05452889Pulmonary Hypertension Association Registry
- University of Pennsylvania, Philadelphia
- Allegheny General Hospital, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
RecruitingObservational study
Ages 0 and older · All sexes · Updated Nov 14, 2025 · NCT04071327Prospective Validation of the Novel PVD-B65 Risk Score in Patients With Chronic Lung Disease and Pulmonary Hypertension
- Temple University Hospital, Philadelphia
RecruitingObservational study
Ages 18 to 99 · All sexes · Updated Sep 3, 2025 · NCT07151768From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.